Latest news with #Sebia
Time of India
15-07-2025
- Health
- Time of India
Agilus launches new antibody test for diagnosing arthritis
New Delhi: Agilus Diagnostics , in collaboration with Sebia , has launched an Anti-MCV (anti–mutated citrullinated vimentin) antibody test that provides early detection of rheumatoid arthritis (RA). Developed by Sebia, the new antibody test enhances the early detection of rheumatoid arthritis (RA), especially in patients who test negative for conventional markers like anti-CCP and rheumatoid factor (RF). 'Studies show that 10–15 per cent of RA cases missed by anti-CCP can be picked up through anti-MCV testing. When patients present with persistent symptoms but test negative for both CCP and RF, anti-MCV offers clinicians a valuable next step,' a statement from the company spokesperson reads. The new antibody test is a highly sensitive and specific biomarker, which detects autoantibodies against a mutated form of the vimentin protein particularly valuable for identifying RA in individuals who test negative for conventional markers such as anti-CCP and rheumatoid factor (RF), the company said. Clinical data also supports the combined use of anti-MCV and anti-CCP to enhance diagnostic accuracy. When used together, these tests can increase sensitivity without compromising specificity, helping to identify RA in its earliest stages, when therapeutic intervention can make the greatest difference, it added.
Yahoo
25-02-2025
- Business
- Yahoo
Capillary Electrophoresis Market Report 2025-2030, with Profiles of Bio-Rad Laboratories, Bio-Techne, Qiagen, Helena Laboratories, Agilent Technologies, PerkinElmer, Danaher, Merck, Shimadzu & more
Capillary Electrophoresis Market Dublin, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The "Capillary Electrophoresis Market Size, Share & Trends Analysis Report By Product (Instruments, Consumable, Software), By Mode, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030" report has been added to global capillary electrophoresis market size was estimated at USD 370.24 million in 2024 and is expected to grow at a CAGR of 5.48% from 2025 to 2030. This growth is attributed to the increasing prevalence of chronic diseases, increasing use in increasingly utilized in drug discovery, pharmacokinetics, and biomarker identification, coupled with rising need for personalized medicines and technological advancements are major factors driving the market. Furthermore, increasing R&D spending in drug discovery and development and rising number of clinical laboratories are likely to drive the market over the forecast period. Capillary electrophoresis (CE) is increasingly utilized in drug discovery, pharmacokinetics, and biomarker identification due to its high resolution, sensitivity, and ability to separate complex mixtures of biomolecules. As pharmaceutical companies focus on precision medicine and personalized therapies, CE plays a crucial role in understanding molecular interactions and disease mechanisms. For instance, the CAPILLARYS 3 OCTA by Sebia is an advanced automated capillary electrophoresis system. It builds on the CAPILLARYS 2 FLEX-PIERCING and shares technology with the CAPILLARYS 3 TERA. It offers a wide range of assays for conditions such as myeloma, diabetes, hemoglobinopathies, and chronic alcohol abuse. Key benefits include a flexible and scalable platform, smart reagent management, advanced piloting software, and high throughput with up to 79 results per hour. It handles multiple sample types, including whole blood, urine, and prevalence of chronic diseases such as cardiovascular disorders, diabetes, and various types of cancer are driving demand for CE's. As it has high resolution and ability to separate complex mixtures of biomolecules such as proteins, nucleic acids, and carbohydrates make it invaluable in identifying disease-specific markers that traditional methods may overlook. In clinical settings, CE facilitates the detection and quantification of biomarkers indicative of chronic diseases like cardiovascular disorders, diabetes, and various types of cancer. The technique allows for rapid and accurate profiling of patient samples, aiding in early diagnosis, disease monitoring, and personalized treatment advancements in electrophoresis systems. The shift towards minimally invasive diagnostics and point-of-care testing further drives the adoption of CE technologies. In addition, Recent technological innovations by manufacturers in capillary coatings, detection systems (e.g., fluorescence detection, mass spectrometry coupling), and automation have improved CE's throughput, sensitivity, and reproducibility. For instance, in September 2021, Sciex Company launched the BioPhase8800, a cutting-edge capillary electrophoresis system, which enables biological characterization during biopharmaceutical therapy. This innovative device allows for the simultaneous analysis of eight samples and features a multi-capillary design for Capillary Electrophoresis Sodium Dodecyl Sulfate (CE-SDS) applications. These advancements reduce analysis time and enhance data accuracy, making CE more attractive for high-throughput screening and routine laboratory capillary electrophoresis industry is characterized by presence of several key players such as Agilent Technologies, Thermo Fisher Scientific, and PerkinElmer. These companies focus on product innovation, strategic collaborations, and mergers/acquisitions to expand their product portfolios and enhance market presence. Additionally, emerging companies and startups are introducing niche CE systems targeting specific applications or technological enhancements, contributing to market initiatives and increasing funding and substantial investments are driving the market, further research organizations worldwide are allocating significant funds towards biotechnology and life sciences research, which includes investments in CE technologies. Funding initiatives aim to accelerate research in areas such as genomics and proteomics, thereby driving market growth. Government funding programs support research initiatives focused on advancing capillary electrophoresis technologies. Funds are directed towards basic research, applied sciences, and translational research aimed at improving healthcare outcomes, environmental monitoring, and agricultural sciences. These investments play a crucial role in driving technological innovations and expanding the utility of capillary electrophoresis across diverse Capillary Electrophoresis Market Report SegmentationThis report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, the analyst has segmented the global capillary electrophoresis market report on the basis of product, mode, application, end use, and region. Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $370.24 Million Forecasted Market Value (USD) by 2030 $507.04 Million Compound Annual Growth Rate 5.4% Regions Covered Global Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segment Outlook2.3. Competitive InsightsChapter 3. Capillary Electrophoresis Market Variables, Trends & Scope3.1. Market Lineage Outlook3.2. Market Dynamics3.2.1. Market driver analysis3.2.1.1. Increasing prevalence of chronic diseases3.2.1.2. Increasing industry academia collaborations3.2.1.3. Rising need for personalized medicines3.2.1.4. Technological advancements3.2.1.5. Increasing funding for genomics and proteomics research3.2.1.6. Rising number of clinical laboratories3.2.2. Market restraint analysis3.2.2.1. Maintaining standardization across different instruments3.2.2.2. Stringent regulations3.3. Capillary Electrophoresis Market Analysis Tools3.3.1. Industry Analysis - Porter's3.3.2. PESTEL AnalysisChapter 4. Capillary Electrophoresis Market: Product Estimates & Trend Analysis4.1. Global Capillary Electrophoresis Market: Product Dashboard4.2. Global Capillary Electrophoresis Market: Product Movement Analysis4.3. Global Capillary Electrophoresis Market by Product, Revenue4.4. Instrument4.5. Consumables4.6. SoftwareChapter 5. Capillary Electrophoresis Market: Mode Estimates & Trend Analysis5.1. Mode Market Share, 2024 & 20305.2. Segment Dashboard5.3. Global Capillary Electrophoresis Market by Mode Outlook5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following5.4.1. Capillary Zone Electrophoresis5.4.2. Capillary Gel Electrophoresis5.4.3. Capillary ElectrochromatographyChapter 6. Capillary Electrophoresis Market: Application Estimates & Trend Analysis6.1. Application Market Share, 2024 & 20306.2. Segment Dashboard6.3. Global Capillary Electrophoresis Market by Application Outlook6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following6.4.1. Nucleic Acid Analysis6.4.2. Protein analysis6.4.3. Genomic DNA6.4.4. Fragment Analysis6.4.5. RNA/mRNA Analysis6.4.6. OthersChapter 7. Capillary Electrophoresis Market: End Use Estimates & Trend Analysis7.1. End Use Market Share, 2024 & 20307.2. Segment Dashboard7.3. Global Capillary Electrophoresis Market by End Use Outlook7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following7.4.1. Research Organizations and Institutes7.4.2. Pharmaceutical and Biotechnology Companies7.4.3. Clinical laboratoriesChapter 8. Capillary Electrophoresis Market: Regional Estimates & Trend Analysis8.1. Regional Market Share Analysis, 2024 & 20308.2. Regional Market Dashboard8.3. Global Regional Market Snapshot8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:8.5. North America8.6. Europe8.7. Asia Pacific8.8. Latin America8.9. MEAChapter 9. Competitive Landscape9.1. Recent Developments & Impact Analysis, By Key Market Participants9.2. Company/Competition Categorization9.3. Vendor Landscape9.3.1. List of key distributors and channel partners9.3.2. Key customers9.3.3. Key company market share analysis, 2024 Bio-Rad Laboratories Thermo Fisher Scientific C.B.S Scientific Bio-Techne Qiagen Helena Laboratories Agilent Technologies PerkinElmer Danaher Merck Shimadzu For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Capillary Electrophoresis Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
